1Peter Walter,David R.The Unfolded Protein Response: From Stress Pathway to Homeostatic Regulation. Science . 2011
2Giovanni Targher,Christopher D. Byrne.Nonalcoholic Fatty Liver Disease: A Novel Cardiometabolic Risk Factor for Type 2 Diabetes and Its Complications[J].The Journal of Clinical Endocrinology & Metabolism.2013(2)
3Dian-liang Fang,Ying Wan,Wei Shen,Jie Cao,Zhong-xin Sun,Hui-hong Yu,Qin Zhang,Wen-hui Cheng,Juan Chen,Bo Ning.Endoplasmic reticulum stress leads to lipid accumulation through upregulation of SREBP-1c in normal hepatic and hepatoma cells[J].Molecular and Cellular Biochemistry (-).2013(1-2)
4Anisha A. Gupte,Christopher J. Lyon,Willa A. Hsueh.Nuclear Factor (Erythroid-Derived 2)-Like-2 Factor (Nrf2), a Key Regulator of the Antioxidant Response to Protect Against Atherosclerosis and Nonalcoholic Steatohepatitis[J].Current Diabetes Reports.2013(3)
5Kosuke Okada,Eiji Warabi,Hirokazu Sugimoto,Masaki Horie,Naohiro Gotoh,Katsutoshi Tokushige,Etsuko Hashimoto,Hirotoshi Utsunomiya,Hiroshi Takahashi,Tetsuro Ishii,Masayuki Yamamoto,Junichi Shoda.Deletion of Nrf2 leads to rapid progression of steatohepatitis in mice fed atherogenic plus high-fat diet[J].Journal of Gastroenterology.2013(5)
6Masahiro Usui,Suguru Yamaguchi,Yasuhiro Tanji,Ryu Tominaga,Yasushi Ishigaki,Manabu Fukumoto,Hideki Katagiri,Kazutoshi Mori,Yoshitomo Oka,Hisamitsu Ishihara.Atf6 α-null mice are glucose intolerant due to pancreatic β-cell failure on a high-fat diet but partially resistant to diet-induced insulin resistance[J].Metabolism.2012(8)
7Shiyu Wang,Zhouji Chen,Vivian Lam,Jaeseok Han,Justin Hassler,Brian N. Finck,Nicholas O. Davidson,Randal J. Kaufman.IRE1α-XBP1s Induces PDI Expression to Increase MTP Activity for Hepatic VLDL Assembly and Lipid Homeostasis[J].Cell Metabolism.2012(4)
8Kenneth Cusi.Role of Obesity and Lipotoxicity in the Development of Nonalcoholic Steatohepatitis: Pathophysiology and Clinical Implications[J].Gastroenterology.2012(4)
9Kosuke Okada,Eiji Warabi,Hirokazu Sugimoto,Masaki Horie,Katsutoshi Tokushige,Tetsuya Ueda,Nobuhiko Harada,Keiko Taguchi,Etsuko Hashimoto,Ken Itoh,Tetsuro Ishii,Hirotoshi Utsunomiya,Masayuki Yamamoto,Junichi Shoda.Nrf2 inhibits hepatic iron accumulation and counteracts oxidative stress-induced liver injury in nutritional steatohepatitis[J].Journal of Gastroenterology.2012(8)
10Christopher D. Williams,Joel Stengel,Michael I. Asike,Dawn M. Torres,Janet Shaw,Maricela Contreras,Cristy L. Landt,Stephen A. Harrison.Prevalence of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among a Largely Middle-Aged Population Utilizing Ultrasound and Liver Biopsy: A Prospective Study[J].Gastroenterology.2011(1)
5Papanikolaou J, Tsolaki V, Makris D, et al. Early levosimendan administration may improve outcome in patients with subarach- noid hemorrhage complicated by acute heart failure [J]. Int J Cardiol, 2014, 176(3).-1435-1437.
6Cullen L,Than M,Peacock WF. Undetectable hs-cTnT in the e- mergency department and risk of myocardial infarction [J]. J Am Coll Cardiol, 2014, 64(6) ;632-633.
7Chon H,Lee S,Yoon SY,et al. SERS-based competitive immu- noassay of troponin I and CK-MB markers for early diagnosis of acutemyocardial infaretion[-J;. Chem Commun (Camb), 2014, 50(9) : 1058-1060.
8Rossignol P, Zannad F, Pitt B. Time to retrieve the best benefits from renin angiotensin aldosterone system (RAAS) inhibition inheart failure patients with reduced ejection fraction: lessons from randomized controlled trials and registries[J]. Int J Cardi- ol, 2014, 177(3);731-733.
9Rengo G, Pagano G, Parisi V, et al. Changes of plasma norepi- nephrine and serum N-terminal pro-brain natriuretic peptide af- ter exereise training predict survival in patients with heart fail- ure[J]. Int J Cardiol, 2014,171 (3) : 384-389.
10Onur S,Niklowitz P,Jacobs G,et al. Association between serum level of ubiquinol and NT-proBNP, a marker for chronic heart failure, in healthy elderly subjects [J]. Biofactors, ;015, 41 (1) ;35 43.
